General discussion, page-5706

Hey @Chaya just been contemplating over the last couple hours your reply to @Glitterati

Your suggestion is that the list should be (in order of release)

- OSA Trial
- Left field announcement
- Dow/Nasdaq Listing
- Details of 2nd Psychedelics trial

Pondering the left-field announcement you said should be followed by the OAS Trial could that be interpreted to mean that we could expect a "left field announcement" that relates to OSA? Is that the reason you suggested it should follow the OAS Trial release?

I wonder what the Board would need to be contemplating at the moment in preparation of some success in the OSA Trial. Apart from Joel's previous announcements stating that a positive OSA result would be an "inflection point for the IHL share price"?

Just Brain Storming here for a minute!!!
Maybe I am over thinking your comment to Glitts today but....

> Wouldn't the Board need to consider another trial?
> Perhaps access to IHL-42X via the Special Access Scheme, would that be possible?
> Perhaps longer-term distribution / partnerships / licensing agreements?
> Would it be too far fetched to perhaps come to an agreement with RESMED who obviously have a lot at stake? ( This BOD - Answer - No! )

If you were on the BOD what would you be considering right now if you were getting positive feedback regarding the IHL-42X trial?

What could the "Left field announcement" be?

I am purely speculating here.....

GLTAH